Among the many ways Trump has shattered White House norms, his impulsive public communications rank among the most consequential. By inspiring investors or spooking them, his...Politicsread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
CNEX, backed by Microsoft and Dell, filed new allegations in a Texas suit accusing China's Huawei and an executive of trade secrets theft.Technologyread more
In a private call with Morgan Stanley clients on Wednesday, research analyst Adam Jones, a long-time Tesla bull, said it's extremely unlikely that big tech firms like Apple or...Technologyread more
Shares of L Brands, the owner of Victoria's Secret and Bath & Body Works, rose nearly 11% in aftermarket trading Wednesday after the company reported it beat revenue and...Retailread more
Officials remained firmly committed to a "patient" policy stance at their meeting earlier this month.The Fedread more
Talk about 5G is everywhere right now, from the trade war with China to the ban on Huawei. Here's what 5G is and why it matters.Technologyread more
"Target's gutsy decision to make its stores the centerpiece of its fulfillment system has turned out to be a brilliant move," Jim Cramer says.Mad Money with Jim Cramerread more
A slew of retail earnings the past two weeks makes it clear that while Americans continue to shop, they aren't ringing registers at department stores.Retailread more
Stocks that would benefit from a federal infrastructure spending program fell after President Trump ended a meeting on infrastructure spending with Democratic leaders.Market Insiderread more
The interaction, witnessed by a senior administration official, followed President Donald Trump's abrupt exit out of a meeting with Democratic congressional leaders.Politicsread more
Shares of health insurer Humana spiked on Friday amid reports the company had received takeover interest.
Humana—which had a market value of about $27 billion before its stock rose Friday—is working with Goldman Sachs on a potential sale, The Wall Street Journal reported, citing sources. Potential bidders for Humana include Aetna and Cigna, according to the newspaper.
Shares of the insurer jumped 19 percent Friday afternoon after a brief trading halt around 1 p.m. ET. Cigna and Aetna were up more than 4 and 2 percent, respectively.
Humana's stock had risen 23 percent this year into Friday afternoon.
Anthem seemed to be "the most likely" bidder, but Cigna and Aetna would make sense, as well, said Tom Carroll, managing director at Stifel Nicolaus. Carroll expects "a wave of consolidation" in the health-care sector.
"Our view was that Anthem and Aetna are both in a position where they must own Humana to maintain relevance long term," Carroll said in a CNBC "Closing Bell" interview.
Humana has emerged as "the big-ticket player" in Medicare, the federal program for older Americans, Carroll said. The company gets most of its sales from patients on the plan, which puts it in a key market position.
Carroll added that Humana will likely be a beneficiary of a changing Medicare landscape moving forward. Next year, he expects the first positive Medicare Advantage rate growth in about five years.
He partially attributed the rate trends to the Affordable Care Act, a key policy of President Barack Obama's administration. The ACA has boosted Humana's potential customer pool, as it requires Americans to have health insurance.
Before Friday's trading, Anthem could have fetched a price of at least $230 per share, Carroll noted. After its 19 percent jump, the shares were trading around $212.
Humana reported $34 billion in revenue last year. In the first quarter, its membership climbed to 14.2 million customers.
Humana, Anthem and Cigna did not immediately responded to requests for comment from CNBC. Aetna declined to comment.